Today: 20 March 2026
Subscribe
Browse Category

NASDAQ:INBS 31 December 2025 - 2 January 2026

INBS stock drops today as Intelligent Bio Solutions’ $10M private placement puts dilution in focus

INBS stock drops today as Intelligent Bio Solutions’ $10M private placement puts dilution in focus

Intelligent Bio Solutions shares fell 12.1% to $8.38 in late morning trading after announcing a $10 million private placement with two tranches of warrants. The deal, priced at $4.35 per share and warrant, follows a manufacturing partnership with Syrma Johari MedTech aimed at cutting costs and boosting margins ahead of a planned 2026 U.S. launch.
2 January 2026
··
INBS stock whipsaws after Intelligent Bio Solutions lines up $10 million funding

INBS stock whipsaws after Intelligent Bio Solutions lines up $10 million funding

Intelligent Bio Solutions shares jumped 132% to $9.53 before dropping 14% after-hours as the company announced a $10 million private placement and a new manufacturing deal with Syrma Johari MedTech. The placement, priced at $4.35 per share and warrants, is set well below the closing price. Volume hit 108 million shares. The company recently enacted a 1-for-10 reverse split after a Nasdaq minimum bid warning.
1 January 2026
··
INBS stock jumps on Syrma Johari deal: Intelligent Bio Solutions targets 40% cost cuts

INBS stock jumps on Syrma Johari deal: Intelligent Bio Solutions targets 40% cost cuts

Intelligent Bio Solutions shares surged 132% to $9.53 Wednesday after announcing a manufacturing deal with Syrma Johari MedTech, targeting over 40% production cost savings and a 20-point gross margin boost. The stock slipped 6% to $8.95 after hours. The company remains under Nasdaq bid-price deficiency notice despite the rally. Market cap stood near $9 million at the close.
31 December 2025
·
INBS stock surges 160% as Intelligent Bio Solutions strikes manufacturing deal targeting 40% cost cuts

INBS stock surges 160% as Intelligent Bio Solutions strikes manufacturing deal targeting 40% cost cuts

Intelligent Bio Solutions shares jumped 160% to $10.66 after announcing a manufacturing deal with Syrma Johari MedTech to scale production of its fingerprint drug-screening device. The company expects over 40% annual production cost savings and a 20-point gross margin boost. Trading volume hit 48.13 million shares, far above average. The stock traded between $5.62 and $11.52 after closing at $4.10 Tuesday.
31 December 2025
··

Stock Market Today

  • Nasdaq Falls as Super Micro AI Chip Smuggling Charges Hit Market
    March 20, 2026, 12:01 PM EDT. The Nasdaq composite dropped about 1% on March 20, 2026, led by a sharp 28.37% plunge in Super Micro Computer shares following charges against its co-founder for conspiring to smuggle $2.5 billion of Nvidia AI chips to China. The indictment alleges complex export control violations, involving fake shipping documents and label swapping to mask shipments through Southeast Asia. Nvidia shares fell 1.66% given their exposure to Super Micro, and AMD dropped 2.32% amid sector-wide unease. The Invesco QQQ Trust also slipped 1%, extending its four-week losing streak amid ongoing geopolitical strains, including Iran tensions and volatile oil prices. Analysts question Super Micro's credibility and internal controls despite the charges targeting individuals rather than the firm itself.
Go toTop